FITC anti-human CD3 Antibody

Product Details

Verified Reactivity

Human

Antibody Type

Monoclonal

Host Species

Mouse

Formulation

Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)

Preparation

The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.

Concentration

Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)

Storage & Handling

The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.

Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood.

Excitation Laser

Blue Laser (488 nm)

Application Notes

The OKT3 monoclonal antibody reacts with an epitope on the epsilon-subunit within the human CD3 complex.

Clone OKT3 can block the binding of clones SK7 and UCHT1.⁴ The OKT3 antibody is able to induce T cell activation. Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen sections and activation of T cells. The LEAF™ purified antibody (Endotoxin <0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 317304). For highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 317326) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin <0.01 EU/µg).

Application References

(PubMed link indicates BioLegend citation)

1. Schlossman S, et al. Eds. 1995. Leucocyte Typing V. Oxford University Press. New York.
2. Knapp W. 1989. Leucocyte Typing IV. Oxford University Press New York.
3. Barclay N, et al. 1997. The Leucocyte Antigen Facts Book. Academic Press Inc. San Diego.
4. Li B, et al. 2005. Immunology 116:487.
5. Jeong HY, et al. 2008. J. Leuckocyte Biol. 83:755. PubMed
6. Alter G, et al. 2008. J. Virol. 82:9668. PubMed
7. Manevich-Mendelson E, et al. 2009. Blood 114:2344. PubMed
8. Pinto JP, et al. 2010. Immunology. 130:217. PubMed
9. Biggs MJ, et al. 2011. J. R. Soc. Interface. 8:1462. PubMed

Product Citations

1. Kim JH, et al. 2020. Sci Rep. 10:1835. PubMed
2. Zhang T, et al. 2022. Am J Reprod Immunol. 87:e13524. PubMed
3. Tessaro FHG, et al. 2022. Cell Rep. 39:110977. PubMed
4. Deepak HB, et al. 2022. Indian J Pharmacol. 54:183. PubMed
5. Rosato F, et al. 2022. J Transl Med. 20:578. PubMed
6. Zhang W, et al. 2022. Front Cell Dev Biol. 10:842813. PubMed
7. Gkika E, et al. 2023. NPJ Precis Oncol. 7:24. PubMed
8. Li D, et al. 2023. Int J Oncol. 62:. PubMed
9. Li L, et al. 2023. Heliyon. 9:e14219. PubMed
10. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
11. Afolabi LO, et al. 2021. Front Immunol. 12:701671. PubMed
12. Guo X, et al. 2016. Mol Ther Methods Clin Dev. 3:15054. PubMed
13. Zitti B, et al. 2017. Sci Rep. 10.1038/s41598-017-10403-0. PubMed
14. Lugo-Reyes SO, et al. 2021. J Clin Immunol. 41:1291. PubMed
15. Hess NJ, et al. 2020. J Immunol. 205:272. PubMed
16. Want MY, et al. 2019. Oncoimmunology. 8:e1586042. PubMed
17. Clayton K, et al. 2014. J Immunol. 192:782. PubMed
18. Shi Z, et al. 2021. Ann Clin Transl Neurol. 8:43. PubMed
19. Catapano M, et al. 2020. J Invest Dermatol. 140:816. PubMed
20. Wu X, et al. 2020. Cancers (Basel). 12:. PubMed
21. Moen IN, et al. 2021. Cell Death Discov. 7:36. PubMed
22. Wang Y, et al. 2019. J Transl Med. 17:93. PubMed
23. Yamada E, et al. 2021. Gut Microbes. 13:1997292. PubMed
24. Zhang B, et al. 2022. J Exp Med. 219:. PubMed
25. Dai Q, et al. 2020. Front Immunol. 11:539654. PubMed
26. Sun Y, et al. 2022. Nat Commun. 13:3916. PubMed
27. Zhang Z, et al. 2021. Acta Pharm Sin B. 11:1965. PubMed
28. Celik H, et al. 2021. Cancer Discov. 11:3126. PubMed
29. Lin L, et al. 2018. Oncol Lett. 16:1259. PubMed
30. Fujigaki J, et al. 2015. PLoS One. 10: 0132521. PubMed
31. Giesecke C, et al. 2017. Cytometry A. 10.1002/cyto.a.23250. PubMed
32. Gillissen MA, et al. 2018. Blood. 131:131. PubMed
33. Sperk M, et al. 2021. iScience. 24:102111. PubMed
34. Nakasone H, et al. 2021. Commun Biol. 4:1177. PubMed
35. Wu X, et al. 2021. Front Immunol. 12:731767. PubMed
36. Jeyanathan M, et al. 2022. JCI Insight. 7:. PubMed
37. Omer OS, et al. 2020. Methods Mol Biol. 2121:199. PubMed
38. James KR, et al. 2020. Nat Immunol. 1.113194444. PubMed
39. Kim K, et al. 2019. Nat Microbiol. 1.586111111. PubMed
40. Hazenberg MD, et al. 2019. Blood Adv. 2.659722222. PubMed
41. Chulpanova DS, et al. 2021. Biology (Basel). 10:. PubMed
42. Golebski K, et al. 2021. Immunity. 54(2):291-307.e7. PubMed
43. Oyer JL, et al. 2022. Front Immunol. 13:861681. PubMed
44. Zhang CR, et al. 2022. Blood Cancer Discov. 3:220. PubMed
45. Agashe VV, et al. 2018. J Immunol. 201:772. PubMed
46. Cheng J, et al. 2022. iScience. 25:103588. PubMed
47. Tsai HI, et al. 2021. EMBO Mol Med. 13:e12834. PubMed
48. Zhang W, et al. 2022. J Transl Med. 20:558. PubMed
49. Aagaard K, et al. 2017. Sci Rep. 7:41389. PubMed
50. Miyamae Y, et al. 2020. Cell Chemical Biology. 27(12):1573-1581.e3. PubMed
51. Winkler C, et al. 2021. JCI Insight. 6:. PubMed
52. Akusjärvi SS, et al. 2022. iScience. 25:103607. PubMed
53. Zhou Z, et al. 2022. J Gastrointest Oncol. 13:732. PubMed
54. Zhao B, et al. 2013. PLoS One. 8:77708. PubMed
55. Bal S, et al. 2016. Nat Immunol. 10.1038/ni.3444. PubMed
56. Loo Yau H, et al. 2021. STAR Protocols. 2(2):100549. PubMed
57. Shikhagaie M, et al. 2017. Cell Rep. 18(7):1761-1773. PubMed
58. Gopalakrishnapillai A, et al. 2021. Cancers (Basel). 13:. PubMed
59. Svensson Akusjärvi S, et al. 2022. Commun Biol. 5:357. PubMed
60. Fierle JK, et al. 2021. Cell Reports Medicine. 2(8):100362. PubMed
61. Sullivan KD et al. 2016. eLife. 5 pii: e16220. PubMed
62. Ochi T, et al. 2011. Blood. 118:1495. PubMed

RRID

AB_571906 (BioLegend Cat. No. 317305)
AB_571906 (BioLegend Cat. No. 317306)

Antigen Details

Structure

Ig superfamily, the subunits CD3γ, CD3δ, CD3ζ (CD247) and TCR (α/β or γ/δ) form the CD3/TCR complex, 20 kD

Distribution

Mature T and NK T cells, thymocyte differentiation

Function

Antigen recognition, signal transduction, T cell activation

Ligand/Receptor

Peptide antigen bound to MHC

Cell Type

NKT cells, T cells, Thymocytes, Tregs

Biology Area

Immunology

Molecular Family

CD Molecules

Antigen References

1. Barclay N, et al. 1993. The Leucocyte FactsBook. Academic Press. San Diego.
2. Beverly P, et al. 1981. Eur. J. Immunol. 11:329.
3. Lanier L, et al. 1986. J. Immunol. 137:2501.

Gene ID

916 View all products for this Gene ID

UniProt

View information about CD3 on UniProt.org

Related Protocols

• Cell Surface Flow Cytometry Staining Protocol

Other Formats